April 27, 2021 Life Science Tools Product Launch

Bio-Techne Announces Commercial Release of Novel DNAscope In Situ Hybridization Assays for Chromogenic Detection of DNA Copy Number and Structural Variations

APRIL 27, 2021 Pushing the Spatial Genomics Frontier One Biomolecule at a Time from RNA to DNA MINNEAPOLIS, April 27, 2021 /PRNewswire/ — Bio-Techne Corporation (NASDAQ:TECH) today announced the expansion of the Advanced Cell Diagnostics (ACD), a Bio-Techne brand, RNAscope™ technology with release of new DNAscope Assays. The RNAscope technology is an advanced in situ hybridization (ISH)... Read more

April 26, 2021 Environ, Ag./Food & Bev Lab Top-10 Product Launch

Danaher Announces Renowned Scientists To Join New Scientific Advisory Board

DIVERSE SCIENTIFIC EXPERTISE AND PROPRIETARY INSIGHTS WILL SUPPORT COMPANY GROWTH AND IMPACT WASHINGTON, April 26, 2021 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (“Danaher”), the global science and technology company, announced today the formation of a Scientific Advisory Board (“Board”) to support its innovation and investment strategy. The Board will help the company protect and grow existing... Read more

April 26, 2021 Life Science Tools Liq. Handling & Robotics Product Launch

Pacific Biosciences Launches New HiFi Sequencing Workflow to Further Improve HiFi’s Industry Leading Accuracy

HiFi Sequencing and Software v10.1 Release on the Sequel II and IIe Systems Increases Scalability, Improves Usability, and Unlocks Additional Sample Types to Extend the Value of HiFi Reads MENLO PARK, Calif., April 26, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB), a global leader offering a comprehensive view of genomes, transcriptomes, and epigenomes,... Read more

April 26, 2021 Life Science Tools Liq. Handling & Robotics Product Launch

Pacific Biosciences Launches New HiFi Sequencing Workflow to Further Improve HiFi’s Industry Leading Accuracy

HiFi Sequencing and Software v10.1 Release on the Sequel II and IIe Systems Increases Scalability, Improves Usability, and Unlocks Additional Sample Types to Extend the Value of HiFi Reads MENLO PARK, Calif., April 26, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB), a global leader offering a comprehensive view of genomes, transcriptomes, and epigenomes,... Read more

April 22, 2021 PR/Corporate Product Launch

Pacific Biosciences Grants Equity Incentive Award to New Employee

MENLO PARK, Calif., April 22, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequencing of genomes, transcriptomes, and epigenomes, today announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 80,000 shares of... Read more

April 22, 2021 Clinical Research/Diagn. Environ, Ag./Food & Bev Licensing, IP, and Legal Life Science Tools M&A, Partnerships Product Launch

Illumina and Kartos Therapeutics Announce New Oncology Partnership to Develop an NGS-Based TP53 Companion Diagnostic

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) and Kartos Therapeutics, Inc. are pleased to announce a new partnership to co-develop a TP53 companion diagnostic (CDx) based on the content of Illumina’s comprehensive genomic profiling assay, TruSight™ Oncology 500 (TSO 500). This companion diagnostic for multiple hematologic indications will be the first to use TSO 500 with... Read more

April 22, 2021 PR/Corporate Product Launch

Pacific Biosciences Grants Equity Incentive Award to New Employee

MENLO PARK, Calif., April 22, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequencing of genomes, transcriptomes, and epigenomes, today announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 80,000 shares of... Read more

April 21, 2021 Chromatography Product Launch

JEOL USA Welcomes New Managing Director, Hidetaka Sawada

April 19, 2021 Peabody, Mass. — JEOL USA welcomes a new Managing Director, Dr. Hidetaka Sawada, to its Peabody, Massachusetts office this April. Dr. Sawada is a world-renowned expert in aberration corrected electron microscopy. Most recently he served as General Manager of the Technical and Development group in the Electron Microscopy Business Unit of JEOL,... Read more

April 16, 2021 Licensing, IP, and Legal Product Launch

New data for Roche’s OCREVUS (ocrelizumab) reinforce significant benefit on slowing disease progression in relapsing and primary progressive multiple sclerosis

85% of treatment-naïve, early-stage relapsing-remitting multiple sclerosis (RRMS) patients achieved no evidence of disease activity (NEDA) in open-label Phase IIIb ENSEMBLE study OCREVUS significantly slowed loss of brain tissue within T2 MRI lesions in primary progressive multiple sclerosis (PPMS) in post-hoc analysis of Phase III ORATORIO study OCREVUS-treated patients show highest adherence and persistence rates... Read more

April 15, 2021 Lab Equipment Product Launch

BioLife Solutions Launches New High Capacity Controlled Rate Freezer Line with First Shipment to a Leading Cell Therapy Developer

BOTHELL, Wash., April 15, 2021 /PRNewswire/ — BioLife Solutions, Inc. (NASDAQ: BLFS) (“BioLife” or the “Company”), a leading developer and supplier of a portfolio of class-defining bioproduction products and services for cell and gene therapies, today announced that it has launched a new line of high capacity controlled rate freezers (HCRF), with an initial shipment to a leading cell therapy... Read more